Conn's syndrome
ICD-10 E26.01 is a billable code used to indicate a diagnosis of conn's syndrome.
Conn's syndrome, also known as primary hyperaldosteronism, is an endocrine disorder characterized by excessive production of the hormone aldosterone from the adrenal glands. This condition leads to sodium retention, potassium excretion, and increased blood volume, resulting in hypertension. The adrenal glands, located on top of each kidney, are responsible for producing various hormones, including aldosterone, cortisol, and adrenaline. In Conn's syndrome, the overproduction of aldosterone can be due to an adrenal adenoma (a benign tumor) or adrenal hyperplasia. Patients often present with symptoms of hypertension, muscle weakness, fatigue, and frequent urination. Diagnosis typically involves measuring plasma aldosterone levels and renin activity, along with imaging studies to identify adrenal abnormalities. Treatment options include surgical removal of the adenoma or medical management with aldosterone antagonists. Proper management of Conn's syndrome is crucial to prevent complications such as cardiovascular disease and renal impairment.
Thorough documentation of hormonal assays, imaging studies, and clinical symptoms.
Patients presenting with resistant hypertension and electrolyte imbalances.
Ensure clear documentation of the diagnostic workup and treatment plan.
Detailed records of renal function tests and electrolyte levels.
Patients with hypertension and renal impairment requiring management of aldosterone levels.
Document any renal complications related to hyperaldosteronism.
Used to confirm diagnosis of Conn's syndrome.
Document the reason for the test and results.
Endocrinologists should ensure comprehensive hormonal evaluation.
Common symptoms include hypertension, muscle weakness, fatigue, and frequent urination due to electrolyte imbalances.
Diagnosis typically involves measuring plasma aldosterone levels, plasma renin activity, and imaging studies to identify adrenal abnormalities.
